FDA Approved: BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION — Original Application (Leading Pharma, LLC)

View source ↗

Summary

FDA approved a generic fixed-dose combination ophthalmic solution of brimonidine tartrate and timolol maleate from Leading Pharma, LLC under an original ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Brimonidine tartrate/timolol maleate ophthalmic solution (brimonidine tartrate and timolol maleate)

Snippet

ORIG AP for BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION (BRIMONIDINE TARTRATE AND TIMOLOL MALEATE)